FR2932680B1 - Association de tiliroside et d'un peptide - Google Patents

Association de tiliroside et d'un peptide

Info

Publication number
FR2932680B1
FR2932680B1 FR0803425A FR0803425A FR2932680B1 FR 2932680 B1 FR2932680 B1 FR 2932680B1 FR 0803425 A FR0803425 A FR 0803425A FR 0803425 A FR0803425 A FR 0803425A FR 2932680 B1 FR2932680 B1 FR 2932680B1
Authority
FR
France
Prior art keywords
tiliroside
peptide
association
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0803425A
Other languages
English (en)
French (fr)
Other versions
FR2932680A1 (fr
Inventor
Olivier Courtin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Clarins SAS
Original Assignee
Laboratoires Clarins SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0803425A priority Critical patent/FR2932680B1/fr
Application filed by Laboratoires Clarins SAS filed Critical Laboratoires Clarins SAS
Priority to PCT/FR2009/000732 priority patent/WO2009153459A1/fr
Priority to US12/999,971 priority patent/US20110144565A1/en
Priority to ES09766021.1T priority patent/ES2445202T3/es
Priority to CA2728155A priority patent/CA2728155A1/fr
Priority to AU2009261809A priority patent/AU2009261809B9/en
Priority to EP09766021.1A priority patent/EP2310031B1/fr
Priority to JP2011514087A priority patent/JP5642068B2/ja
Publication of FR2932680A1 publication Critical patent/FR2932680A1/fr
Application granted granted Critical
Publication of FR2932680B1 publication Critical patent/FR2932680B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0803425A 2008-06-19 2008-06-19 Association de tiliroside et d'un peptide Expired - Fee Related FR2932680B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0803425A FR2932680B1 (fr) 2008-06-19 2008-06-19 Association de tiliroside et d'un peptide
US12/999,971 US20110144565A1 (en) 2008-06-19 2009-06-18 Combination of a tiliroside and a peptide
ES09766021.1T ES2445202T3 (es) 2008-06-19 2009-06-18 Asociación de tilirosida y lisina-valina 5 diaminohidroxibutirato
CA2728155A CA2728155A1 (fr) 2008-06-19 2009-06-18 Association de tiliroside et d'un peptide
PCT/FR2009/000732 WO2009153459A1 (fr) 2008-06-19 2009-06-18 Association de tiliroside et d'un peptide
AU2009261809A AU2009261809B9 (en) 2008-06-19 2009-06-18 Combination of a tiliroside and a peptide
EP09766021.1A EP2310031B1 (fr) 2008-06-19 2009-06-18 Association de tiliroside et de lysine-valine 5 diaminohydroxybutyrate
JP2011514087A JP5642068B2 (ja) 2008-06-19 2009-06-18 ティリロサイドとペプチドとの組合せ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803425A FR2932680B1 (fr) 2008-06-19 2008-06-19 Association de tiliroside et d'un peptide

Publications (2)

Publication Number Publication Date
FR2932680A1 FR2932680A1 (fr) 2009-12-25
FR2932680B1 true FR2932680B1 (fr) 2010-08-27

Family

ID=40202183

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0803425A Expired - Fee Related FR2932680B1 (fr) 2008-06-19 2008-06-19 Association de tiliroside et d'un peptide

Country Status (8)

Country Link
US (1) US20110144565A1 (https=)
EP (1) EP2310031B1 (https=)
JP (1) JP5642068B2 (https=)
AU (1) AU2009261809B9 (https=)
CA (1) CA2728155A1 (https=)
ES (1) ES2445202T3 (https=)
FR (1) FR2932680B1 (https=)
WO (1) WO2009153459A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012036128A (ja) * 2010-08-06 2012-02-23 Oriza Yuka Kk コラーゲン産生促進剤及びそれを用いた美肌用組成物
JP2013213015A (ja) * 2012-04-04 2013-10-17 Morishita Jintan Co Ltd Ｔｉｅ２活性化剤
ES2754222T3 (es) * 2015-02-24 2020-04-16 Tecnologia Para La Medicina Y La Estetica S L Procedimiento para el tratamiento cosmético de la piel
CN114828872B (zh) * 2019-10-18 2023-07-25 安佳榜控股股份公司 育毛剂
US20230390356A1 (en) * 2020-09-24 2023-12-07 Adjuvant Holdings Co., Ltd. Hair growth agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847182A3 (de) * 2001-03-02 2010-03-31 MERCK PATENT GmbH Nahrungsmittel oder Nahrungsergänzungsmittel enthaltend Flavonoid-Derivate
DE10214257A1 (de) * 2002-03-28 2003-10-16 Merck Patent Gmbh Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden
DE10240923A1 (de) * 2002-09-02 2004-03-04 Merck Patent Gmbh Flavonoid-Derivate zur Ekzem-Behandlung

Also Published As

Publication number Publication date
EP2310031A1 (fr) 2011-04-20
AU2009261809B9 (en) 2014-06-05
CA2728155A1 (fr) 2009-12-23
FR2932680A1 (fr) 2009-12-25
WO2009153459A1 (fr) 2009-12-23
AU2009261809B2 (en) 2014-01-30
US20110144565A1 (en) 2011-06-16
ES2445202T3 (es) 2014-02-28
EP2310031B1 (fr) 2013-11-20
JP2011524885A (ja) 2011-09-08
AU2009261809A1 (en) 2009-12-23
JP5642068B2 (ja) 2014-12-17

Similar Documents

Publication Publication Date Title
EP2368114A4 (en) PREDICTION AND PREVENTION OF PREECLAMPSY
BRPI0911743A2 (pt) "peptídeo"
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
EP2013701A4 (en) DISAMBING OF NAMED CHARACTERS
EP2377028A4 (en) CHANGE OF COMMANDS
BRPI0907064A2 (pt) "métodos e sistemas"
EP2334226A4 (en) COGNITION AND LINGUISTIC TESTING BY EYE TRIAL
EP2123673A4 (en) NEURONAL EXOCYTOSIS-INHIBITING PEPTIDES
EP2211714A4 (en) PROOF OF IMPEDANCE
EP2268673A4 (en) POLYPEPTIDE POLYMER CONJUGATES AND METHOD OF USE THEREOF
EP2316414A4 (en) HAIR CARE COMPOSITION
EP2382734A4 (en) VERIFICATION OF SOFTWARE APPLICATIONS
IL197501A0 (en) Modifications of cupredoxin derived peptides and methods of use thereof
BRPI1014926A2 (pt) "montagem de aplicador de trilho e aplicador de trilho"
IL208979B (en) Humanized antibodies against human interferon-alpha
EP2346521A4 (en) PEPTIDES AND USE METHOD THEREFOR
FR2944062B1 (fr) Injecteur d'ergols
EP2126076A4 (en) PROTEINS FROM THE NETWORKS OF SPIDERS NEPHILENGYS CRUENTATA, AVICULARIA JURUENSIS AND PARAWIXIA BISTRIATA
BRPI0914354A2 (pt) "métodos e artigos"
EP2237658A4 (en) homogenizer valve
EP2462237A4 (en) METHOD FOR IMPROVING THE EXPRESSION OF RECOMBINANT PROTEINS
EP2350857A4 (en) BOOTSTRAP REDENZVOUSPUNKTERING
EP2283352A4 (en) Acetaminophen TEST PROCEDURE
IT1395539B1 (it) Piede d'appoggio
EP2083845A4 (en) ABLATIVE IMMUNOTHERAPY

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160229